Sign In
NewsRadar

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.
   

Past Press Releases - Oxford Immunotec Ltd.

November 22, 2013
Oxford Immunotec Global PLC Announces Pricing of Initial Public Offering
Oxford Immunotec Global PLC (NASDAQ: OXFD) (the 'Company') announced today that its initial public offering of 5,360,000 ordinary shares priced at $12.00 per share. More

January 29, 2013
Oxford Immunotec and Lophius Biosciences Sign Licensing and Collaboration Agreements
Oxford Immunotec, a medical diagnostic company developing tests in the fields of infectious and immunological disease and Lophius Biosciences, a leader in the field of novel T-cell based diagnostic test systems, announced today that the companies have signed agreements under which both companies will have access to certain intellectual property from the other party. More

June 18, 2012
Oxford Immunotec raises $28m to accelerate commercial sales map
Oxford Immunotec, a medical diagnostic company developing tests in the fields of infectious and immunological disease, announced today that it has raised a total of $28m in a new equity financing. More

June 25, 2010
The T-SPOT.TB test now included in new CDC guidelines
TB blood tests preferred for targeted groups. More

March 23, 2010
Oxford Immunotec announces contract with Scancell to measure T cell response in immunotherapy trial
Oxford Immunotec announces contract with Scancell Ltd to measure T cell response in Phase I/II clinical immunotherapy trial. More

August 1, 2008
T-SPOT.TB gains FDA premarket approval
Oxford Immunotec, the global T-cell diagnostic company, today announced that the U.S. Food and Drug Administration (FDA) has approved a premarket approval application (PMA) for the T-SPOT.TB test. More

May 23, 2008
Study results confirm T-SPOT.TB performance is not affected by low CD4 count in HIV infected subject
Oxford Immunotec, the T cell measurement company, today announced the publication of a recent study, demonstrating the efficacy of using T-SPOT.TB to identify TB infection in HIV infected subjects. More

April 20, 2007
Study results confirm utility of T-SPOT ® .TB as a rapid rule out test for tuberculosis disease
Oxford Immunotec Ltd, the T cell measurement company, announced the publication of a recent study demonstrating the use of T-SPOT.TB with non-blood samples and its use as a rule out test for active TB disease. More

April 6, 2007
Oxford Immunotec Grants License over T-SPOT® technology to sanofi pasteur for human vaccine research
Oxford Immunotec

  • has licenced its technology to sanofi pasteur, the vaccines business of the sanofi-aventis Group, which offers the broadest range of human vaccines.
  • has settled its patent disputes with sanofi pasteur. More

    March 23, 2007
    Oxford Immunotec Announces appointment of President – North America
    Oxford Immunotec Announces appointment of President North America and filing for FDA approval for T-SPOT.TB More

    November 4, 2005
    Oxford Immunotec Wins Medical Futures Innovation Award
    Oxford Immunotec's revolutionary new blood test for diagnosing TB infection, called T-SPOTTM.TB has won the Equinox-sponsored award for the Best Business Proposition at the Medical Futures Innovation Awards 2005. More

    September 21, 2005
    Millipore and Oxford Immunotec co-develop plates for diagnosing and monitoring infections
    Millipore Corporation and Oxford Immunotec Ltd. announced the co-development of a specially designed microtitre plate for use in clinical diagnostics kits. More

    August 3, 2005
    Oxford Immunotec closes £7m in Series B financing
    Oxford Immunotec, the T cell diagnostics company, announced today that it has closed a 7M series B private equity financing. More

  • Data


    26,261
    Tech investments
    From our Online Data Service
    16,961
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Oct 19€3.0MInternet services
    Oct 19€6.0MBusiness applications
    Oct 18€11.0MConsumer electronics
    Oct 18€5.0MBusiness applications
    Oct 18€2.3MInternet services
    Oct 17€5.9MBiopharmaceuticals
    Oct 16€51.0MArtificial Intelligence

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    May 28
    Identiq
    identiq raises $5m seed, launches privacy-first identity validation...

    Apr 29
    Nethone
    nethone raised over $1 million from innovation nest

    Oct 1
    The Link App
    the link app launches version 2.0

    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase

    Jan 2
    Urban Jungle
    urban jungle raises 1m in seed funding to build tech-enabled home ...





    About usContact usLegal Information
    Copyright 1999-2019
    Emerging Technology Research Europe Inc. All rights reserved.